Christopher Bunka

Insider Reports History

Location
Kelowna, British Columbia, Canada
Signature
/Chris Bunka/
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Bunka:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lexaria Bioscience Corp. Director common shares 281,912 $202,976 $0.7200 17 Mar 2026 Private Holding Company
Lexaria Bioscience Corp. Director common shares 273,543 $196,950 $0.7200 17 Mar 2026 Direct
Lexaria Bioscience Corp. Director Stock Options 184,834 $133,080 $0.7200 17 Mar 2026 Direct

Insider Reports Filed by Christopher Bunka

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LEXX Lexaria Bioscience Corp. 17 Mar 2026 1 $0 4 Director 18 Mar 2026, 11:37
LEXX Lexaria Bioscience Corp. 29 Jul 2025 2 +$25,241 4 Director 30 Jul 2025, 17:12
LEXX Lexaria Bioscience Corp. 15 May 2025 1 $0 4 Director 16 May 2025, 17:39
LEXX Lexaria Bioscience Corp. 07 Jan 2025 1 $0 4 Director 10 Jan 2025, 11:52
LEXX Lexaria Bioscience Corp. 26 Apr 2024 1 $0 4 Chief Executive Officer, Director 10 May 2024, 16:44
LEXX Lexaria Bioscience Corp. 26 Oct 2023 1 $0 4 Chief Executive Officer, Director 30 Oct 2023, 12:30
LEXX Lexaria Bioscience Corp. 12 Oct 2022 2 +$78,397 4/A Chief Executive Officer, Director 18 Oct 2022, 18:20
LEXX Lexaria Bioscience Corp. 29 Aug 2022 1 $0 4 Chief Executive Officer, Director 29 Aug 2022, 17:18
LEXX Lexaria Bioscience Corp. 01 Sep 2021 1 $0 4 CEO, Director 02 Sep 2021, 13:58
LEXX Lexaria Bioscience Corp. 08 Jun 2021 1 $0 4 CEO, Director 09 Jun 2021, 12:57
LEXX Lexaria Bioscience Corp. 07 May 2021 1 $0 4 CEO, Director 09 Jun 2021, 12:48